Affiliation:
1. Cardiothoracic Department, Fondazione Toscana Gabriele Monasterio, Pisa, Italy; Health Science Interdisciplinary Center, Scuola Superiore Sant’Anna, Pisa, Italy
2. Cardiothoracic Department, Fondazione Toscana Gabriele Monasterio, Pisa, Italy
Abstract
Imaging has a central role in the diagnosis, classification, and clinical management of cardiomyopathies. While echocardiography is the first-line technique, given its wide availability and safety, advanced imaging, including cardiovascular magnetic resonance (CMR), nuclear medicine and CT, is increasingly needed to refine the diagnosis or guide therapeutic decision-making. In selected cases, such as in transthyretin-related cardiac amyloidosis or in arrhythmogenic cardiomyopathy, the demonstration of histological features of the disease can be avoided when typical findings are observed at bone-tracer scintigraphy or CMR, respectively. Findings from imaging techniques should always be integrated with data from the clinical, electrocardiographic, biomarker, genetic and functional evaluation to pursue an individualised approach to patients with cardiomyopathy.
Publisher
Radcliffe Media Media Ltd
Subject
Cardiology and Cardiovascular Medicine
Reference130 articles.
1. Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008;29:270–6. https://doi.org/10.1093/eurheartj/ehm342; PMID: 17916581.
2. Garcia-Pavia P, Rapezzi C, Adler Y, et al. Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur J Heart Fail 2021;23:512–26. https://doi.org/10.1002/ejhf.2140; PMID: 33826207.
3. Casas G, Rodríguez-Palomares JF. Multimodality cardiac imaging in cardiomyopathies: from diagnosis to prognosis. J Clin Med 2022;11:578. https://doi.org/10.3390/jcm11030578; PMID: 35160031.
4. Rankin K, Thampinathan B, Thavendiranathan P. Imaging-specific cardiomyopathies a practical guide. Heart Fail Clin 2019;15:275–95. https://doi.org/10.1016/j.hfc.2018.12.007; PMID: 30832818.
5. Cardim N, Galderisi M, Edvardsen T, et al. Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging endorsed by the Saudi Heart Association. Eur Heart J Cardiovasc Imaging 2015;16:280. https://doi.org/10.1093/ehjci/jeu291; PMID: 25650407.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献